Presumed prevalence analysis on suspected and highly suspected breast cancer lesions in São Paulo using BIRADS® criteria

Sao Paulo Medical Journal

Volumn 125, Issue 4, 2007, Pages 210-214

  Milani, Vivian ^a   Goldman, Suzan Menasce ^a   Finguerman, Flora ^a   Pinotti, Marianne ^b   Ribeiro, Celso Scazufka ^c   Abdalla, Nitamar ^a   Szejnfeld, Jacob ^a  

^a FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

^b Programa de Reproducao Assistida   (Brazil)

^c Health Department   (Brazil)

Author keywords

Breast neoplasm; Determination; Epidemiology; Mammography; Statistics

Indexed keywords

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; BRAZIL; BREAST CANCER; BREAST IMAGING REPORTING AND DATA SYSTEM; CANCER INCIDENCE; CANCER SCREENING; CONTROLLED STUDY; CRITERION VARIABLE; FEMALE; HEALTH PROGRAM; HUMAN; MAJOR CLINICAL STUDY; MAMMOGRAPHY; POPULATION RESEARCH; PREVALENCE; RISK FACTOR;

EID: 36749071097     PISSN: 15163180     EISSN: None     Source Type: Journal    
DOI: 10.1590/s1516-31802007000400003     Document Type: Article

References (31)

1. Tabar L, Fagerberg G, Chen HH, et al. Efficacy of breast cancer screening by age. New results from the Swedish Two-Country Trial. Cancer. 1995;75(10):2507-17.
2. a ed. Rio de Janeiro Pro-Onco; 1997.
3. Shapiro S. Evidence on screening for breast cancer from a raxidomized trial. Cancer. 1977;39(6 Suppl):2772-82.
4. Kopans M. The usc of mammography for screening. JAMA. 1994;271(13):982-3.
5. Smith RA. LARC Handbooks of Cancer Prevention, Volume 7: Breast Cancer Screening. Breast Cancer Res. 2003;5(4):216-7. Available from: http://www.pubmedcentral.nih.gov/articler-ender.fcgi?artid=165025. Accessed in 2007 (May 24).
6. Ministério da Saúde. Instituto Nacional de Câncer. Documento de, Consenso. Estimativa/2006. Incidência de Câncer no Brasil. Available from: http://www.inca.gov.br/ estimativa/2006/. Accessed in 2007 (May 24).
7. American College of Radiology. Breast imaging reporting and data system. 3rd ed. Reston: American College of Radiology; 1998.
8. American College of Radiology. ACR Practice guideline for the performance of diagnostic mammography. Diagnostic mammography. 2002:405-9. Available from http://www.acr.org/sr_ac/ bin.asp?CID-549&cDID=12208&DOC=FILE.PDF. Accessed in 2007 (May 24).
9. Kemp C, Petti DA, Quadros LGO. Câncer de mama - prevenção primária. Projeto Diretrizes. São Paulo: Associação Médica Brasileira e Conselho Federal de Medicina. Sociedade Brasileira de Mastologia e Federação Brasileira das Sociedad de Ginecologia e Obstarícia; 2002. Available from http:www.projetodiretrizes.org.br/projcto_dirctrizes/025.pdf Accessed in 2007 (May 24).
10. Tabar L, Duffy SW, Chen HH. Quantitative interpretation of age-specific mortality reductions from the Swedish Breast Cancer-Screening Trials. J Natl Cancer Inst. 1996;88(1):52-5.
11. Wright CJ, Mueller CB. Screening mammography and public health policy: the need for perspective. Lancet. 1995;346(8966):29-32.
12. Dershaw DD, Yahalom J, Petrek JA. Breast carcinoma in women previously treated for Hodgkin disease: mammographic evaluation. Radiology. 1992;184(2):421-3.
13. Smigel K. Breast cancer death faces decline for white women. J Natl Cancer Inst. 1995;87(3):173.
14. Olsen O, Gotzsche PC. Cochrane review on screening for breast cancer with mammography. Lancet. 2001;358(9290):1340-2.
15. Lee CH. Screening mammography: proven benefit, continued controversy. Radial Clin North Am. 2002;40(3):395-407.
16. Fletcher SW, Black W, Harris R, Rimer Bk, Shapiro S. Report, of the International Workshop on Screening for Breast Cancer. J Nat Cancer Inst. 1993;85(20):1644-56:
17. Shapiro S. The status of breasr cancer screening: a quarter of a century of research. World J Surg. 1989;13(1):9-18.
18. Baker LH. Breast Cancer Detection Demonstration Project: five-year summary report. CA Cancer J Clin. 1982;32(4):194-225.
19. Tabar L, Vitak B, Chen HH, Yen MF. Duffy SW, Smith RA. Beyond randomiwd controlled trials: organized mammographic screening substantially reducts, breast carcinoma mortality. Cancer. 2001;91(9):1724-31.
20. Feig SA. Effect of service screening mammography on population mortality from breast carcinoma. Cancer. 2002;95(3):451-7.
21. Baines CJ, Miller AB, Kopans DB, et al. Canadian National Breast Screening Study: assessment of technical quality by external review. AJR Am J Roentgenol. 1990;155(4):743-7; discussion 748-9.
22. Frisell J, Glas U, Hellstrom L, Somell A. Randomized mammographic screening for breast cancer in Stockholm Design, first round results and comparisons. Breast Cancer Res Treat. 1986;8(1):45-54
23. Kopans DB, Feig SA. The Canadian National Breast Screening Study: a critical review. AJR Am J Roentgenol. 1993;161(4):755-60.
24. van der Mass PJ, de Koning HJ, van Ineveld BM, et al. The cost-effectiveness of breast cancer screening. Int J Cancer. 1989;43(6):1055-60.
25. Kopans DB, Monsees B, Feig SA. Screening for cancer. when is it valid? - Lessons from the mammography esperience. Radiology. 2003;229(2):319-27.
26. Sickles EA, Kopans DB. Deficiencies in the analysis of breast cancer screening data. J Natl Cancer Inst. 1993;85(20):1621-4.
27. Berlin L. Breast cancer, mammography, and malpractice litigation: the controversies continue. AJR Am J Roentgenol. 2003;180(5):1229-37.
28. Humphrey LL, Helfand M, Chan BK. Woolf SH. Breast cancer screening: a summary of the evidence for the U.S. Preventive Services Task Force. Ann Intern Med. 2002;137(5 Part 1):347-60.
29. Alexander FE, Anderson TJ, Brown HK et al. 14 years of follow-up from the Edinburghrandomised trial of breast-cancer screening. Lancet. 1999;353(9168):1903-8.
30. American Cancer Society. Breast cancer facts and figures 2001-2002. Atlanta: American Cancer Society, 2002. Available from: http://www.cancer.org/downloads/STT/BrCaFF2001.pdf. Accessed in 2007 (May 25).
31. Bird RE, Wallac TW, Yankaskas BC. Analysis of cancers missed at screening mammography. Radiology. 1992;184(3):613-7.